OptumRx Adds AxelaCare to Enhance Pharmacy Care Services for Patients
November 17 2015 - 9:00AM
Business Wire
Home infusion innovator complements OptumRx’s
specialty pharmacy offering
Strengthens care integration and clinical
services for patients with complex medical conditions
OptumRx, the pharmacy care services business of Optum, announced
it has acquired AxelaCare Health Solutions, a leading provider of
home infusion solutions. The addition of AxelaCare continues
OptumRx’s strategy of improving care and reducing costs by
integrating information and services on behalf of those it
serves.
With an aging population accessing new and more medications,
AxelaCare enhances OptumRx’s ability to deliver the best care to
the growing number of consumers managing complex conditions through
at-home infusions. Together, AxelaCare and OptumRx will expand the
scope of treatments that can be offered in the home rather than in
higher-cost institutional settings.
AxelaCare’s industry-first electronic patient outcomes
assessment technology, CareExchange® captures and reports real-time
patient-specific data on the clinical efficacy of drug regimens.
CareExchange will work together with Optum’s analytics tools to
support treatment decisions and OptumRx’s synchronized approach to
medical and pharmacy care.
“AxelaCare’s at-home services will enable us to more effectively
support the growing number of people managing complex conditions,
many of whom require infusions that increasingly involve
higher-cost specialty medications,” said Mark Thierer, CEO of
OptumRx. “We look forward to adding AxelaCare’s broad spectrum of
therapy solutions to bring consumers higher-quality, more
cost-effective infusion service at home, where we know they prefer
to get well and stay well.”
Larry Renfro, chief executive officer of Optum said “AxelaCare’s
sophisticated approach to treating patients with complex clinical
conditions will be further enhanced by Optum’s ability to deliver
more actionable information to the precise point of care, yielding
greater value for customers and consumers.”
AxelaCare currently treats patients in 44 states and Washington,
D.C. through its network of registered nurses. The company offers
chronic drug therapies from unaffiliated manufacturers through its
network of 34 pharmacies, for conditions such as autoimmune disease
and hemophilia, as well as acute infusion therapies including
antibiotics and total parenteral nutrition.
“OptumRx’s differentiated pharmacy care services model that goes
beyond prescriptions to leverage industry-leading data, technology
and scale, will help AxelaCare deliver on our promise to improve
the health of the people and communities we serve,” said Ted Kramm,
CEO of AxelaCare. “Our shared focus on creating more connected
experiences will support better treatment decisions, health
outcomes and cost savings for patients and customers.”
Through its service to more than 65 million people through a
broad base of payer and employer clients, OptumRx will accelerate
the introduction of AxelaCare’s progressive approach to home
infusion care to a broader market.
About OptumRx and Optum
OptumRx is an innovative pharmacy care services company managing
the prescription drug benefits of commercial, Medicare, Medicaid
and other government health plans, as well as those of employers
and unions through a national network of 67,000 community
pharmacies and state-of-the-art home delivery pharmacies which have
earned the prestigious Verified Internet Pharmacy Practice Sites™
(VIPPS) accreditation by the National Association of Boards of
Pharmacy. OptumRx is part of Optum, a leading information and
technology-enabled health services business dedicated to making the
health system work better for everyone. Visit www.optum.com for
more information about OptumRx. Optum is the technology-enabled
health services business of UnitedHealth Group (NYSE:UNH), serving
approximately 300 payers and nearly 115 million individuals.
Click here to subscribe to Mobile Alerts for UnitedHealth
Group.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151117005637/en/
OptumDrew Krejci, 952-205-6652andrew.krejci@optum.com
UnitedHealth (NYSE:UNH)
Historical Stock Chart
From Mar 2024 to Apr 2024
UnitedHealth (NYSE:UNH)
Historical Stock Chart
From Apr 2023 to Apr 2024